Last updated: August 16, 2021
Sponsor: University Hospital, Brest
Overall Status: Active - Recruiting
Phase
N/A
Condition
Hematologic Neoplasms
Neoplasms
Lymphocytic Leukemia, Acute
Treatment
N/AClinical Study ID
NCT05009537
CARTOGEN - 29BRC21.0211
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Minor/Major Patients
- Patients with suspected hemopathies for whom we receive a sample for diagnosis in thechromosomal genetics laboratory or for whom a diagnosis of hemopathy has already beenmade.
- No objection made or consent given
Exclusion
Exclusion Criteria:
- Patients under judicial protection (guardianship, curatorship, ...),
- Refusal to participate
Study Design
Total Participants: 200
Study Start date:
September 01, 2021
Estimated Completion Date:
September 30, 2026
Connect with a study center
CHRU de Brest
Brest, 29609
FranceActive - Recruiting
CH Morlaix, service d'hémato clinique
Morlaix,
FranceActive - Recruiting
CHIC, service d'hémato clinique
Quimper,
FranceActive - Recruiting
CH St Brieuc, service d'hémato clinique
Saint-Brieuc,
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.